LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Business Contracts

Securities Purchase Agreement (Filed With SEC on April 15, 2022)

Amendment to Employment Agreement between the Company and Eric Forman (Filed With SEC on March 26, 2021)

Form of Underwriter Agreement (Filed With SEC on November 16, 2020)

Form of Placement Agents Warrant (Filed With SEC on April 15, 2022)

Securities Purchase Agreement (Filed With SEC on March 2, 2021)

Form of Placement Agents Warrant (Filed With SEC on March 2, 2021)

Form of Public Warrant (Filed With SEC on November 27, 2020)

Warrant Agency Agreement, dated as of November 25, 2020, between the Company and Computershare (Filed With SEC on November 27, 2020)

Form of Warrant Agent Agreement (Filed With SEC on November 16, 2020)

Form of Warrant included in Unit (Filed With SEC on November 16, 2020)

Form of Underwriter Agreement (Filed With SEC on October 13, 2020)

Employment Agreement with Robert Weingarten (Filed With SEC on August 18, 2020)

Master Service Agreement with Foundation of Angelman Syndrome Therapeutics FAST (Filed With SEC on August 18, 2020)

Employment Agreement with Dr. James Miser (Filed With SEC on July 17, 2020)

Employment Agreement with Eric Forman (Filed With SEC on July 17, 2020)

Employment Agreement with Dr. John Kovach (Filed With SEC on July 17, 2020)

Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan (Filed With SEC on July 17, 2020)

Clinical Trial Research Agreement1 (Filed With SEC on August 6, 2019)

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (22)